Shandong Pharmaceutical Glass Co., Ltd., a leading name in the pharmaceutical packaging industry, is headquartered in China (CN) and operates extensively across major regions. Established in 1970, the company has achieved significant milestones, positioning itself as a trusted supplier of high-quality glass containers for the pharmaceutical sector. Specialising in the production of pharmaceutical glass vials, ampoules, and bottles, Shandong Pharmaceutical Glass is renowned for its commitment to quality and innovation. Their products are designed to meet stringent international standards, ensuring safety and reliability for pharmaceutical applications. With a strong market presence, the company has garnered recognition for its advanced manufacturing techniques and sustainable practices, solidifying its reputation as a key player in the global pharmaceutical glass market.
How does Shandong Pharmaceutical Glass Co.Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shandong Pharmaceutical Glass Co.Ltd's score of 7 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong Pharmaceutical Glass Co. Ltd, headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or reduction initiatives available, it is unclear how Shandong Pharmaceutical Glass Co. Ltd is addressing its carbon footprint or contributing to climate action within the pharmaceutical glass industry. The lack of reported data may suggest an opportunity for the company to enhance its transparency and commitment to sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shandong Pharmaceutical Glass Co.Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

